Millions of people suffer from sleep apnea every single night.
We will not rest until they sleep peacefully.

We are Invicta Medical™

Sleep apnea is a chronic condition that impacts over 55 million adults in the USA with 80% undiagnosed.

1B

Sleep Apnea Sufferers Worldwide*

80%

Undiagnosed

 $150B

Economic Impact of Sleep Apnea in the US*

When untreated, sleep apnea is linked to serious and costly conditions, including drug-resistant hypertension, obesity, congestive heart failure, type-2 diabetes, atrial fibrillation and more.


Untreated sleep apnea costs the U.S. approximately $150 billion annually, due to the healthcare costs associated with these untreated conditions, as well as loss of productivity, workplace accidents and motor vehicle accidents.


Current solutions are not working. Continuous positive airway pressure (CPAP) therapy accounts for 85% of diagnosed sleep apnea patients, yet nearly half don’t comply with the therapy. The devices are cumbersome, loud, uncomfortable and overall intrusive.

Patients need a better option.

Invicta Medical is changing the sleep apnea treatment paradigm from high-cost, complex machines, to smart, comfortable and cost-effective solutions.

Invicta Medical is a clinical-stage medical technology company developing a first-of-its-kind treatment for sleep apnea.

Invicta’s intelligent neurostimulation system is designed to address the shortcomings of existing therapies, which are expensive, intrusive and yield low patient compliance rates.


Invicta has raised $29.5M in funding since 2020 and is backed by leading investors.


Invicta’s Board of Directors have extensive operational and financial experience in medical technologies and life sciences, while its Scientific Advisors hail from top universities and medical institutions, including University of Pennsylvania, Vanderbilt University, Stanford University, Flinders University, and Monash University.

a black and white logo for shangbay capital
the logo for greatpoint says that they make no little plans
a forepont capital partners logo on a white background
a logo for dns capital with a sun on it
a black and white logo for eclipse on a white background
a black and white logo for supermoon capital
a black and white logo for aphelion capital
Invicta Medical

We Keep People Breathing

Executive Team

a man in a suit and white shirt stands with his hands behind his back
Tim Fayram
Dennis Potts
Rick O'Connor
Chief Executive Officer
Tim Fayram
VP Clinical Research
Dennis Potts
VP Engineering

Rick O'Connor

Chief Executive Officer

(Bio)

Tim Fayram

VP Clinical Research

(Bio)

Dennis Potts

VP Engineering

(Bio)

Darlene Crockett-Billig
Guillaume Raux
Tim Ciciarelli
Darlene Crockett-Billig
VP Regulatory and Quality Affairs ( C )
Guillaume Raux
VP Clinical Affairs
Guillaume Raux
VP Systems, Electrical

Darlene Crockett-Billig

VP Regulatory and Quality Affairs ( C )

(Bio)

Guillaume Raux

VP Clinical Affairs

(Bio)

Tim Ciciarelli

VP Systems, Electrical

(Bio)

Board of Directors

Rick O'Connor
Konstantinos Alataris, PhD
Ismail Kola
Rick O'Connor
Chief Executive Officer
Konstantinos Alataris, PhD
Ismail Kola
Forepont Capital
Erik Engelson
ShangBay Capital

Rick O'Connor

Chief Executive Officer

(Bio)

Konstantinos Alataris, PhD

Chairman

(Bio)

Ismail Kola

Forepont Capital

(Bio)

Andrew Perlman
Andrew Perlman
Seth Winterroth
Mike Masterson
Andrew Perlman
GreatPoint Ventures
Seth Winterroth

Erik Engelson

ShangBay Capital

(Bio)

Andrew Perlman

GreatPoint Ventures

(Bio)

Seth Winterroth

Eclipse VC

(Bio)

Mike Masterson

Supermoon Capital

(Bio)

Eclipse VC
(Bio)
Mike Masterson

Mike Masterson

Supermoon Capital
(Bio)

World-class investor syndicate supports demonstrated best-in-class obstructive sleep apnea solution...

Read Press Release

Sign up for news about our latest developments

SIGN UP FOR NEWS
Share by: